Biomeme Labs
Inflammation Compass™: Peptide & Recovery Edition

What's Your Peptide Actually Doing?

If you're using peptides under a provider's guidance, the Inflammation Compass™ evaluates how your protocol shapes systemic biology. We measure whole-blood RNA expression across the 3 Health Domains — Activation, Antiviral Response, and Resolution — plus cellular deconvolution, tracking downstream inflammatory calming and active resolution capacity in circulating leukocytes.

Why Monitor

Because
Hope Isn't Data

Most peptide protocols operate without cellular feedback. Whole-blood transcriptomics provides an objective biological window into systemic inflammatory tone, oxidative balance, and active resolution capacity.

Systemic Inflammatory Tone

Peptide protocols target complex biological pathways. Whole-blood RNA tracking provides an objective readout of front-line inflammatory cascades and immune activation.

Active Resolution Capacity

Tissue repair requires active biochemical stand-down signaling. Monitoring evaluates whether your body's resolution and homeostatic clearing programs are actively engaged.

Oxidative Balance

Cellular stress and redox equilibrium shift across recovery and wellness regimens. Gene expression patterns measure oxidative stress response and mitochondrial signaling.

Beyond Subjective Feeling

“I think it's working” isn't the same as measurable biological response. Longitudinal transcriptomics provides objective molecular context across your protocol.

The Authentic Molecular Architecture

The 3 Health Domains +
Cellular Deconvolution

Peptide protocols (such as BPC-157, TB-500, Epitalon, or MOTS-c) are evaluated via their systemic anti-inflammatory, oxidative, and resolution signatures in circulating leukocytes — not by measuring peptide-receptor binding or local tissue repair enzymes directly. The Inflammation Compass™ organizes thousands of gene transcripts into three separately scored Health Domains plus cellular deconvolution.

Domain 01

Activation

Innate & Effector Programs

Quantifies danger sensing, IL-1 signaling cascades, neutrophil/monocyte deployment, and oxidative stress programs. Tracks whether peptides like BPC-157 or TB-500 are successfully downregulating chronic systemic inflammatory tone.

Domain 02

Antiviral Response

Type I Interferon Cascade

Measures baseline interferon-stimulated gene modules in circulating leukocytes. Ensures peptide protocols do not provoke off-target immune activation while distinguishing viral defense from systemic metabolic response.

Domain 03

Resolution

Stand-Down Machinery

Quantifies active biological stand-down checkpoints and apoptotic clearance machinery. Peptide protocols aim not merely to suppress symptoms, but to actively engage the resolution programs that restore systemic tissue balance.

Deconvolution

Cellular Deconvolution

Census Plus Orders

Deconvolves whole-blood RNA into circulating immune cell subsets (neutrophils, monocytes, naive and memory lymphocytes) — distinguishing true transcriptional reprogramming from simple shifts in cell counts.

Diagnostic Boundary: The Inflammation Compass™ is a whole-blood RNA sequencing test performed by Biomeme Labs. Circulating leukocytes do not directly express localized musculoskeletal peptide receptors or measure local tissue histology. Instead, they provide an objective, high-sensitivity readout of your body's systemic inflammatory tone and active resolution capacity.

Your dashboard updates with each testing node, building a longitudinal molecular picture of your systemic response over time.

Ready for Molecular
Clarity?

The Inflammation Compass™ is available now to establish your baseline profile and measure dynamic cellular response.